Nicole Lynn Kovacic1,2, David J Gagnon3,4, Richard R Riker3,4, Sijin Wen5, Gilles L Fraser3,4. 1. WVU Medicine, Morgantown, WV, USA. 2. West Virginia University School of Pharmacy, Morgantown, WV, USA. 3. 92602Maine Medical Center, Portland, ME, USA. 4. Tufts University School of Medicine, Boston, MA, USA. 5. Health Science Center, 24041West Virginia University, Morgantown, WV, USA.
Abstract
BACKGROUND: Psychoactive medications (PM) are frequently administered in the intensive care unit (ICU) to provide comfort. Interventions focused on preventing their continuation after the acute phase of illness are needed. OBJECTIVE: To determine the frequency that patients with ICU-initiated PM are continued upon ICU and hospital discharge. METHODS: This single-center, prospective, observational study assessed consecutive adult ICU patients who received scheduled PM. Frequency of PM continued at ICU and hospital discharge was recorded. The patient's primary treatment team was contacted by the pharmacist within 72 hours of ICU discharge to establish rationale for continued use or to suggest discontinuation. RESULTS: Of the 60 patients included, 72% were continued on PM at ICU discharge and 30% at hospital discharge. The pharmacist contacted 40% of treatment teams after ICU discharge and intervention resulted in PM discontinued in 50% of patients. Post ICU discharge, the indication of 41% of patients' PM was unknown by the non-ICU care team or incorrect. Medical ICU patients or those transferred to an outside facility were more likely remain on PM at hospital discharge. CONCLUSION: PM are frequently continued during transitions of care and often without knowledge of the initial indication. Future studies should establish effective PM stewardship methods.
BACKGROUND: Psychoactive medications (PM) are frequently administered in the intensive care unit (ICU) to provide comfort. Interventions focused on preventing their continuation after the acute phase of illness are needed. OBJECTIVE: To determine the frequency that patients with ICU-initiated PM are continued upon ICU and hospital discharge. METHODS: This single-center, prospective, observational study assessed consecutive adult ICU patients who received scheduled PM. Frequency of PM continued at ICU and hospital discharge was recorded. The patient's primary treatment team was contacted by the pharmacist within 72 hours of ICU discharge to establish rationale for continued use or to suggest discontinuation. RESULTS: Of the 60 patients included, 72% were continued on PM at ICU discharge and 30% at hospital discharge. The pharmacist contacted 40% of treatment teams after ICU discharge and intervention resulted in PM discontinued in 50% of patients. Post ICU discharge, the indication of 41% of patients' PM was unknown by the non-ICU care team or incorrect. Medical ICU patients or those transferred to an outside facility were more likely remain on PM at hospital discharge. CONCLUSION: PM are frequently continued during transitions of care and often without knowledge of the initial indication. Future studies should establish effective PM stewardship methods.
Entities:
Keywords:
atypical antipsychotics; medication reconciliation; medication safety; psychoactive medications; transitions of care
Authors: Lisa-Ann Fraser; Kuan Liu; Kyla L Naylor; Y Joseph Hwang; Stephanie N Dixon; Salimah Z Shariff; Amit X Garg Journal: JAMA Intern Med Date: 2015-03 Impact factor: 21.873
Authors: David J Gagnon; Richard R Riker; Elizabeth K Glisic; Andrew Kelner; Hilary M Perrey; Gilles L Fraser Journal: Pharmacotherapy Date: 2015-03 Impact factor: 4.705
Authors: A Shaun Rowe; Leslie A Hamilton; Rachel A Curtis; Camellia R Davis; Leslie N Smith; Grayson K Peek; Victoria W Reynolds Journal: J Crit Care Date: 2015-08-18 Impact factor: 3.425
Authors: Rina P Patel; Meredith Gambrell; Theodore Speroff; Theresa A Scott; Brenda T Pun; Joyce Okahashi; Cayce Strength; Pratik Pandharipande; Timothy D Girard; Hayley Burgess; Robert S Dittus; Gordon R Bernard; E Wesley Ely Journal: Crit Care Med Date: 2009-03 Impact factor: 7.598
Authors: Damon C Scales; Hadas D Fischer; Ping Li; Arlene S Bierman; Olavo Fernandes; Muhammad Mamdani; Paula Rochon; David R Urbach; Chaim M Bell Journal: J Gen Intern Med Date: 2016-02 Impact factor: 5.128
Authors: John Marshall; Shoshana J Herzig; Michael D Howell; Stephen H Le; Chris Mathew; Julia S Kats; Jennifer P Stevens Journal: J Crit Care Date: 2015-12-30 Impact factor: 3.425
Authors: Yoonyoung Park; Brian T Bateman; Dae Hyun Kim; Sonia Hernandez-Diaz; Elisabetta Patorno; Robert J Glynn; Helen Mogun; Krista F Huybrechts Journal: BMJ Date: 2018-03-28